Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy.
Purity:
98.5%
CAS Number:
[219649-07-7]
* VAT and and shipping costs not included. Errors and price changes excepted